|
Dermatology
1996;193(1):65-66
Interferon-induced vitiligo in a patient with
chronic viral hepatitis C infection.
Simsek H, Savas
C, Akkiz H, Telatar H Hacettepe University Medical
School, Department of Internal Medicine, Ankara,
Turkey.
http://www.hepatitis-central.com/Hepatitis C Virus/ifn/vitiligo.html
Vitiligo is an autoimmune disease characterized by
depigmentation of the skin due to destruction of
melanocytes. Interferons have been used for the
treatment of chronic hepatitis C and some
malignancies. We report interferon alpha-2a-induced
vitiligo in a male patient with chronic active
hepatitis C. All skin lesions disappeared completely
without requiring therapy after discontinuation of
interferon. This case suggests that vitiligo may be
developed during interferon therapy as a side effect.
Publication Types:
Review Review of
reported cases
PMID: 8864627, UI:
97018010
|
